Telo Genomics a Rare Gainer Friday As Appoints John Farlinger to Board

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Telo Genomics a Rare Gainer Friday As Appoints John Farlinger to Board

, MT Newswires - 10:27 AM ET 4/4/2025 default

10:27 AM EDT, 04/04/2025 (MT Newswires) -- Biotech company Telo Genomics ( TDSGF ) is a rare gainer across Canadian stock markets on Friday, edging up from near 52 week lows, after announcing that John Farlinger has joined its board of directors, and will chair the company's audit committee.

Farlinger is a veteran venture and private equity-backed executive and entrepreneur, bringing more than 30 years of experience in telecom, operations, technology and finance. He currently serves as Assure Neuromonitoring's executive chairman and chief executive officer.

The company's shares were last seen up $0.01, to $0.11, on the TSX Venture Exchange.

Price: 0.11, Change: +0.01, Percent Change: +10.00

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.